U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8643186431Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy ToddlersCompletedHas ResultsMeningococcal Disease|Meningococcal MeningitisBiological: MenC-CRM LIQ|Biological: MenC-CRM ROS|Biological: MenC-CRM EMVhttps://ClinicalTrials.gov/show/NCT01434680
8643286432Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IVActive, not recruitingNo Results AvailableMild Cognitive ImpairmentBehavioral: APOE genotype disclosure and Alzheimer's disease risk disclosure|Behavioral: Alzheimer's disease risk disclosurehttps://ClinicalTrials.gov/show/NCT01434667
8643386433Efficacy of Neuro-HAART in Patients With HIVNot yet recruitingNo Results AvailableHIVhttps://ClinicalTrials.gov/show/NCT01434654
8643486434Rapid Stress/Rest Single-Day Tc-99m Sestamibi Myocardial Single Photon Emission Computed TomographyRecruitingNo Results AvailableCoronary Artery DiseaseOther: myocardial perfusion SPECThttps://ClinicalTrials.gov/show/NCT01434641
8643586435Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Non-Surgical Circumcision When Performed by NursesCompletedNo Results AvailableMale Circumcision|HIV PreventionDevice: PrePexâ„¢ devicehttps://ClinicalTrials.gov/show/NCT01434628
8643686436Medtronic South Asian Systolic Heart Failure RegistryActive, not recruitingNo Results AvailableHeart FailureDevice: CRT|Other: No-CRThttps://ClinicalTrials.gov/show/NCT01434615
8643786437Phase I-II Everolimus and Sorafenib in Recurrent High-Grade GliomasRecruitingNo Results AvailableBrain Neoplasms|Central Nervous System NeoplasmsDrug: Everolimus|Drug: Sorafenibhttps://ClinicalTrials.gov/show/NCT01434602
8643886438Effects of a Manualized Short-term Treatment of Internet and Computer Game AddictionRecruitingNo Results AvailableAddictionBehavioral: STICA Interventionhttps://ClinicalTrials.gov/show/NCT01434589
8643986439Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative ColitisWithdrawnNo Results AvailableUlcerative ColitisBiological: HGS1025|Biological: HGS1025|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01434576
8644086440The Prevalence of Neurocognitive Disorder in a Primary Care-based HIV Cohort Compared to a HIV-negative Control Cohort -CompletedNo Results AvailableHIV-1-Associated Cognitive Motor Complexhttps://ClinicalTrials.gov/show/NCT01434563
8644186441Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic CancerWithdrawnNo Results AvailablePancreatic TumorRadiation: Stereotactic Body Radiation Therapy (SBRT)|Radiation: Tissue, Blood, Research Imaging (TBRI)https://ClinicalTrials.gov/show/NCT01434550
8644286442Evaluation of a Touchless Vein Scanner for Venepuncture and Cannulation in Pediatric PatientsCompletedNo Results AvailableVenepuncturehttps://ClinicalTrials.gov/show/NCT01434537
8644386443Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino AcidsCompletedNo Results AvailableLiver CancerDrug: LIVACThttps://ClinicalTrials.gov/show/NCT01434524
8644486444Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia ATerminatedHas ResultsHemophilia ABiological: OBI-1https://ClinicalTrials.gov/show/NCT01434511
8644586445GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) InfectionCompletedNo Results AvailableChronic Genotype 1a or 1b HCV InfectionDrug: GS-5885 tablet|Drug: GS-9451 tablet|Drug: tegobuvir capsule|Drug: ribavirin tablet|Drug: placebo matching ribavirin tablet|Device: placebo matching tegobuvir capsulehttps://ClinicalTrials.gov/show/NCT01434498
8644686446Nexium Capsules Clinical Experience InvestigationCompletedNo Results AvailableGastric Ulcer, Duodenal Ulcer, Anastomotic Ulcer, Reflux Oesophagitis,"Non-erosive Reflux Disease, Zollinger-Ellison Syndromehttps://ClinicalTrials.gov/show/NCT01434485
8644786447High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell LymphomaRecruitingNo Results AvailableB-cell Adult Acute Lymphoblastic Leukemia|Post-transplant Lymphoproliferative Disorder|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|ReRadiation: indium In 111 ibritumomab tiuxetan|Radiation: yttrium Y 90 ibritumomab tiuxetan|Biological: rituximab|Radiation: total-body irradiation|Procedure: allogeneic hematopoietic stem cell transplantation|Drug: fludarabine phosphate|Drug: cyclosporine|Drug: mycophenolate mofetil|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT01434472
8644886448Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary OriginTerminatedNo Results AvailablePancreatic Neoplasms|CholangiocarcinomaDrug: Gemcitabine with TheraSpherehttps://ClinicalTrials.gov/show/NCT01434459
8644986449The Effect of Sound Stimulation on Hearing AbilityCompletedNo Results AvailableSensorineural Hearing LossBehavioral: Sound stimulationhttps://ClinicalTrials.gov/show/NCT01434446
8645086450Alere Triage fs B-type Natriuretic Peptide (BNP) Method Comparison EvaluationCompletedNo Results AvailableSpecimens With BNP Values of 5 to 5000 pg/ml|Triagehttps://ClinicalTrials.gov/show/NCT01434433
8645186451Triple Negative Breast Cancer: Study of Molecular and Genetic FactorsActive, not recruitingNo Results AvailableBreast CancerGenetic: BRCA1 BRCA2 PTEN PALB2 mutationhttps://ClinicalTrials.gov/show/NCT01434420
8645286452Effects of Advanced Glycation Endproducts on Satiety and InflammationCompletedNo Results AvailableObesity|Type 2 Diabetes|Insulin Resistance|Cardiovascular DiseaseOther: Dietary meal interventionhttps://ClinicalTrials.gov/show/NCT01434407
8645386453Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal CancerRecruitingNo Results AvailableLocally Advanced Malignant Neoplasm|Oral Cancer|Oropharyngeal Carcinoma|Effects of ChemotherapyDrug: Neo-adjuvant Erbitux-based chemotherapyhttps://ClinicalTrials.gov/show/NCT01434394
8645486454Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)CompletedNo Results AvailableMalariaBiological: Pfs25-EPA/Alhydrogelhttps://ClinicalTrials.gov/show/NCT01434381
8645586455A Longitudinal Investigation of the Endocrine and Neurobiologic Events Accompanying PubertyRecruitingNo Results AvailableAdolescent Developement|Brain|Developmental Biologyhttps://ClinicalTrials.gov/show/NCT01434368
8645686456DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or SiblingsRecruitingNo Results AvailableChildhood Malignant Ovarian Germ Cell Tumor|Childhood Malignant Testicular Germ Cell Tumor|Ovarian Choriocarcinoma|Ovarian Embryonal Carcinoma|Ovarian Mixed Germ Cell Tumor|Ovarian Teratoma|Ovarian Yolk Sac Tumor|Testicular Choriocarcinoma|Testicular EmbrOther: laboratory biomarker analysis|Other: questionnaire administrationhttps://ClinicalTrials.gov/show/NCT01434355
8645786457Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer PatientsActive, not recruitingNo Results AvailableLung Cancer|Tobacco Use Disorder|Breast Cancer|Colorectal Cancer|Prostate CancerDrug: Nicotine Replacement Patchhttps://ClinicalTrials.gov/show/NCT01434342
8645886458S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid LeukemiaActive, not recruitingNo Results AvailableLeukemiaGenetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: microarray analysis|Other: laboratory biomarker analysis|Other: medical chart reviewhttps://ClinicalTrials.gov/show/NCT01434329
8645986459Veliparib and Dinaciclib With or Without Carboplatin in Treating Patients With Advanced Solid TumorsRecruitingNo Results AvailableAdvanced Malignant Neoplasm|BRCA1 Mutation Carrier|BRCA2 Mutation CarrierDrug: Carboplatin|Drug: Dinaciclib|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Veliparibhttps://ClinicalTrials.gov/show/NCT01434316
8646086460Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab OnlyRecruitingNo Results AvailableHER2/Neu Positive|Invasive Breast Carcinoma|Male Breast Carcinoma|Recurrent Breast Carcinoma|Stage IV Breast CancerDrug: Entinostat|Other: Laboratory Biomarker Analysis|Drug: Lapatinib Ditosylate|Biological: Trastuzumabhttps://ClinicalTrials.gov/show/NCT01434303

* Görseller ve İçerik tekif hakkına sahip olabilir